Dr. Gary Rosner, Professor Emeritus of Oncology, Division of Biostatististics and Bioinformatics in the Department of Oncology, since joining the faculty at Johns Hopkins University in February 2010. He also was Director of the Quantitative Sciences Program and led the Biostatistics Shared Resource in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He currently serves as Subject Matter Expert VII (Contractor) with the US Food and Drug Administration’s
Oncology Center of Excellence.

He received his Sc.D. in Biostatistics from the Harvard School of Public Health. He was a member of the faculties of Yale University, Duke University, and The University of Texas M. D. Anderson Cancer Center. He has been actively involved in collaborative research, teaching, and mentoring.

Dr. Rosner has extensive experience in clinical research. In addition to collaborating with clinical researchers at his home institutions, he was a faculty statistician in the Statistical Office of the Cancer and Leukemia Group B (CALGB) for 12 years. He served as a biostatistics expert on the Investigational Drug Steering Committee (IDSC) of the National Cancer Institute and co-chaired the Clinical Trials Design Task Force of the IDSC. He has collaborated on NIH-funded research in pharmacogenomics.

Dr. Rosner’s biostatistical research concerns Bayesian methods, clinical trial design, population pharmacokinetics, pharmacodynamic modeling, and survival analysis.